


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.75%
+2.03%
-4.38%
+1.23%
+1.77%
VSTM
Verastem
$8.52
Chart
$9.29 (-8.29%)
$8.23 (+3.52%)
$5.19 (+64.16%)
$3.93 (+116.79%)
VSTM has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

High volatilty

VSTM overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
![]()
VSTM Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
VSTM Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is VSTM current stock price?
What are VSTM stock strengths?
What risks are associated with VSTM stock?
When is VSTM next earnings report?
What is VSTM market cap and volume?
What is VSTM's current Stock IQ?
Should I buy VSTM stock right now?
Is VSTM a Strong Buy right now?
What does a 'Strong Buy' rating mean for VSTM?
What does a 'Strong Sell' rating mean for VSTM?
What factors influence VSTM's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.75%
+2.03%
-4.38%
+1.23%
+1.77%
VSTM
Verastem
Current Price
$8.52
Stock Insights
Not Enough Information

Chart
$9.29 (-8.29%)
$8.23 (+3.52%)
$5.19 (+64.16%)
$3.93 (+116.79%)
VSTM Analysts Opinion
VSTM Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
![]()
VSTM Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
VSTM Street Sentiment is extremely bullish and have positive views on the near-term outlook
VSTM has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

High volatilty

Average key support and resistance price levels.
VSTM Latest Analysis
KRAS Inhibitors Market to Witness Explosive Growth at a CAGR of 35% During the Forecast Period (2025–2034) Amid Expanding Therapeutic Landscape | DelveInsight. KRAS Inhibitors Market to Witness Explosive Growth at a CAGR of 35% During the Forecast Period (2025–2034) Amid Expanding Therapeutic Landscape |. DelveInsightThe KRAS inhibitors market is expected to experience substantial growth driven by rising cancer incidence improved treatment access and a robust pipeline including Olomorasib (E
Wed Nov 12, 2025
Verastem Oncology drops despite Q3 double beat.
Tue Nov 4, 2025
Verastem Non-GAAP EPS of -$0.54 beats by $0.07 revenue of $11.2M beats by $5.44M.
Tue Nov 4, 2025
Verastem Inc. (VSTM) Delivers Positive Preliminary Data for VS-7375 in Mutant Solid Tumors Treatment. Verastem Inc. (NASDAQ:VSTM) is one of the top long-term biotechnology stocks to buy. On October 23 Verastem Inc. (NASDAQ:VSTM) reported positive preliminary results from an ongoing phase 1/2a dose-escalation trial of vs-7375 an oral KRAS G12D (on/off) inhibitor in patients with KRAS G12D-mutant solid tumors. The preliminary safety and tolerability data indicate that VS-7375 can [….]
Wed Oct 29, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
VSTM Stock trends
VSTM Stock performance
VSTM Stock analysis
VSTM investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.